GLP-1RAs with proven CV benefit are recommended in patients with T2D and CVD or at very high/high CV risk to reduce CV events (class I, level A), while liraglutide is also recommended to reduce the risk of death (class I, level B) (20)
A brightening skincare duo with glutathione and niacinamide to fade dark spots, even tone, and boost radiance
Comparative Effectiveness of Outpatient Cardiovascular Disease and Diabetes Care Delivery Between Advanced Practice Providers and Physician Providers in Primary Care: Implications for Care Under the Affordable Care Act
28.7% average weight loss
The combination of structural resistance to DPP-4 and prolonged half-life via HSA fusion allows for once-weekly administration, positioning albiglutide as a viable and efficacious GLP-1 receptor agonist for long-term glycemic control [14]
10.1095/biolreprod.110.084426 108 LydrupM